Aura Biosciences, Inc. (AURA)

NASDAQ: AURA · IEX Real-Time Price · USD
17.02
-0.64 (-3.62%)
May 20, 2022 4:00 PM EDT - Market closed

Balance Sheet (Quarterly)

Millions USD. Fiscal year is Jan - Dec.
Quarter Ended2022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302019-12-31
Cash & Equivalents
108.41149.0981.8592.23-17.41-32.47
Short-Term Investments
24.9000-0-0
Cash & Cash Equivalents
133.3149.0981.8592.23017.41032.47
Cash Growth
-756.23%-184.06%----
Other Current Assets
6.284.621.610.65-1.04-0.88
Total Current Assets
139.58153.783.4692.88-18.46-33.35
Property, Plant & Equipment
6.726.25.545.32-3.57-3.63
Long-Term Investments
0.130.130.130.13-0.08-0.08
Other Long-Term Assets
001.580.34-0-0
Total Long-Term Assets
6.846.337.255.78-3.65-3.71
Total Assets
146.42160.0390.798.65-22.1-37.06
Accounts Payable
1.962.41.742.42-0.61-2.33
Current Debt
0.620.620.610.6-0-0
Other Current Liabilities
2.424.263.492.3-2.05-3.82
Total Current Liabilities
57.275.835.32-2.66-6.15
Long-Term Debt
0.210.360.510.66-0-0.05
Other Long-Term Liabilities
0.130.080.070.12-0.08-0.1
Total Long-Term Liabilities
0.330.440.580.78-0.08-0.14
Total Liabilities
5.347.726.426.1-2.74-6.29
Total Debt
0.830.981.121.26-0-0.05
Debt Growth
---2475.51%----
Common Stock
306.06304.459.498.9108.1707.27
Retained Earnings
-164.97-152.14-140.5-131.67--116.89--94.68
Comprehensive Income
-0.01000-0-0
Shareholders' Equity
141.09152.32-131.02-122.75--108.71--87.41
Total Liabilities and Equity
146.42160.03-124.6-116.650-105.970-81.11
Net Cash / Debt
132.47148.1180.7390.97017.41032.42
Net Cash / Debt Growth
-750.63%-180.59%----
Net Cash Per Share
4.5328.70182.87217.07-45.75-6.99
Working Capital
134.58146.4377.6387.56-15.79-27.2
Book Value Per Share
4.8329.52-296.79-292.92--285.63--18.86
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).